Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanomaNat Commun 2021 Aug 27;[EPub Ahead of Print], L Ny, H Jespersen, J Karlsson, S Alsén, S Filges, C All-Eriksson, B Andersson, A Carneiro, H Helgadottir, M Levin, I Ljuslinder, R Olofsson Bagge, VR Sah, U Stierner, A Ståhlberg, G Ullenhag, LM Nilsson, JA Nilsson
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.